🔎 Trials Near Me

Inicio › Enfermedad de Alzheimer › California

Ensayos clínicos de Enfermedad de Alzheimer en California

48 estudios sobre Enfermedad de Alzheimer buscan participantes en California.

Ciudades en California

Texto oficial del estudio (inglés)

A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

  • Clinical Site, Anaheim
  • Clinical Site, Long Beach
  • Clinical Site, Murrieta
  • y 2 más
ReclutandoFase 2
Edades de 55 a 90 · Todos los sexos · Actualizado el 30 sept 2026 · NCT06887192

A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease

  • Advanced Research Center, Inc, Anaheim
  • Sunwise Clinical Research, Walnut Creek
ReclutandoFase 2
Edades de 55 en adelante · Todos los sexos · Actualizado el 29 sept 2026 · NCT06540833

A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)

  • Local Institution - 1657, Anaheim
  • Local Institution - 1668, Fresno
  • Local Institution - 2625, Long Beach
  • y 6 más
ReclutandoFase 3
Edades de 55 a 90 · Todos los sexos · Actualizado el 28 sept 2026 · NCT06937229

A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)

  • Progeny Psychiatric Clinic - Irvine, Irvine
  • ATP Clinical Research, Inc - Orange, Orange
ReclutandoFase 4
Edades de 50 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT07633470

A Study to Evaluate the Drug Levels, Absolute Bioavailability, Safety, Tolerability, and Immunogenicity of Single-Dose of BMS-986446 in Healthy Adults After Single-dose Administration, and Participants With Early Alzheimer's Disease After Multiple Dose Administration

  • CenExel ACT (Formerly Anaheim Clinical Trials; LLC), Anaheim
ReclutandoFase 1Se aceptan voluntarios sanos
Edades de 18 a 80 · Todos los sexos · Actualizado el 24 sept 2026 · NCT07780383

A Study of LY3439539 in Participants With Alzheimer's Disease

  • Irvine Clinical Research, Irvine
  • Healthy Brain Clinic, Long Beach
  • Inglewood Clinical, Los Angeles
  • y 1 más
ReclutandoFase 1
Edades de 50 a 85 · Todos los sexos · Actualizado el 24 sept 2026 · NCT07598370

A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease

  • Oakland Clinical- Site Number : 8400010, Oakland
ReclutandoFase 2
Edades de 55 a 85 · Todos los sexos · Actualizado el 22 sept 2026 · NCT07688213

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

  • Advanced Research Center, Inc., Anaheim
  • Inland Psychiatric Medical Group (IPMG)-Chino, Chino
  • USC - The Memory and Aging Center (MAC) - Alzheimer Disease Research Center (ADRC), Los Angeles
ReclutandoFase 3
Edades de 55 a 90 · Todos los sexos · Actualizado el 22 sept 2026 · NCT06585787

Predicting Pre-dementia

  • Foster Carr MD, San Diego
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 55 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07516119

A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

  • Profound Research LLC, Carlsbad
  • Irvine Clinical Research, Irvine
  • UCSD - Altman Clinical and Translational Research Institute (ACTRI), La Jolla
  • y 1 más
ReclutandoFase 2
Edades de 55 a 85 · Todos los sexos · Actualizado el 22 sept 2026 · NCT07589595

Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease

  • Esperanza Clinical, Murrieta
  • Oakland Clinical Research, Oakland
  • ATP Clinical Research, Inc., Orange
  • y 2 más
ReclutandoFase 2
Edades de 55 a 80 · Todos los sexos · Actualizado el 21 sept 2026 · NCT06847321

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

  • Sun Valley Research Center, Inc., Imperial
  • Irvine Center for Clinical Research, Irvine
  • Healthy Brain Clinic, Long Beach
  • y 5 más
ReclutandoFase 3
Edades de 50 a 90 · Todos los sexos · Actualizado el 21 sept 2026 · NCT07177352

A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease

  • Irvine Center for Clinical Research /ID# 277752, Irvine
ReclutandoFase 1/2
Edades de 50 a 90 · Todos los sexos · Actualizado el 18 sept 2026 · NCT07599670

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

  • Fullerton Neurology and Headache Center, Fullerton
  • Irvine Clinical Research, Irvine
  • Inglewood Clinical, Los Angeles
  • y 1 más
ReclutandoFase 3
Edades de 60 a 85 · Todos los sexos · Actualizado el 17 sept 2026 · NCT06976203

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)

  • Advanced Research Center (ARC) - Anaheim, Anaheim
  • Local Institution - 1668, Fresno
  • The Neurology Group, Pomona
  • y 1 más
ReclutandoFase 3
Edades de 55 a 90 · Todos los sexos · Actualizado el 16 sept 2026 · NCT07011732

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease

  • National Institute of Clinical Research, Garden Grove
  • Local Institution - 2607, Long Beach
  • Accellacare, Long Beach
  • y 4 más
ReclutandoFase 3
Edades de 55 a 90 · Todos los sexos · Actualizado el 16 sept 2026 · NCT07011745

A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease

  • Irvine Center for Clinical Research, Irvine
  • Syrentis Clinical Research, Santa Ana
ReclutandoFase 3
Edades de 55 a 80 · Todos los sexos · Actualizado el 10 sept 2026 · NCT07717411

Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders

  • Saddleback Medical Center, Orange
Reclutando
Edades de 70 en adelante · Todos los sexos · Actualizado el 8 sept 2026 · NCT05929703

Alzheimer's Tau Platform: Master Protocol

  • University of California, San Francisco, San Francisco
ReclutandoFase 2
Edades de 50 a 80 · Todos los sexos · Actualizado el 8 sept 2026 · NCT06957418

Large-coil Parietal Repetitive Transcranial Magnetic Stimulation (rTMS) for Alzheimer Disease (AD)

  • UCLA TMS Clinical and Research Service, Los Angeles
ReclutandoFase 1/2
Edades de 55 a 100 · Todos los sexos · Actualizado el 4 sept 2026 · NCT06597942

Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

  • Local Institution - 0017, Anaheim
  • Inland Psychiatric Medical Group., Chino
  • Kaizen Brain Center, La Jolla
  • y 3 más
ReclutandoFase 2
Edades de 55 a 90 · Todos los sexos · Actualizado el 1 sept 2026 · NCT06808984

A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)

  • Irvine Clinical Research ( Site 1041), Irvine
  • Healthy Brain Clinic ( Site 1005), Long Beach
  • Inglewood Clinical ( Site 1062), Los Angeles
  • y 3 más
ReclutandoFase 2
Edades de 50 a 85 · Todos los sexos · Actualizado el 26 ago 2026 · NCT07033494

Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease

  • Stanford Medical Center, Palo Alto
Reclutando
Edades de 50 en adelante · Todos los sexos · Actualizado el 24 ago 2026 · NCT07178210

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease

  • Healthy Brain Clinic, Long Beach
  • Anderson Clinical Research, Redlands
ReclutandoFase 3
Edades de 60 a 85 · Todos los sexos · Actualizado el 20 ago 2026 · NCT06976216

Establishing Normal Cognitive Test Scores for Adults Using a Voice-Enabled Digital Testing Platform Across the Lifespan

  • The Neurology Center of Southern California, Carlsbad
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 18 a 100 · Todos los sexos · Actualizado el 17 ago 2026 · NCT07763392

Senicapoc in Alzheimer's Disease

  • University of California, Davis Alzheimer's Disease Center, Sacramento
  • UC Davis Alzheimer's Disease Center East Bay, Walnut Creek
ReclutandoFase 2Se aceptan voluntarios sanos
Edades de 55 a 85 · Todos los sexos · Actualizado el 17 ago 2026 · NCT04804241

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

  • University of California, San Diego (UCSD) - Medical Center, La Jolla
  • University of California, Los Angeles (UCLA) - David Geffen School of Medicine, Los Angeles
  • University of California, San Francisco (UCSF), San Francisco
  • y 1 más
ReclutandoFase 3
Edades de 18 a 75 · Todos los sexos · Actualizado el 4 ago 2026 · NCT06563895

A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

  • University of California San Diego Medical Center, La Jolla
  • University of Southern Califonria, Los Angeles
ReclutandoFase 2/3Se aceptan voluntarios sanos
Edades de 18 en adelante · Todos los sexos · Actualizado el 27 jul 2026 · NCT05552157

A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

  • University of California San Diego Medical Center, La Jolla
  • University of Southern Califonria, Los Angeles
ReclutandoFase 2/3Se aceptan voluntarios sanos
Edades de 18 en adelante · Todos los sexos · Actualizado el 27 jul 2026 · NCT06647498

A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

  • Care Access - Huntington Beach, Huntington Beach
  • Irvine Clinical Research, Irvine
  • Healthy Brain Clinic, Long Beach
  • y 6 más
ReclutandoFase 3
Edades de 55 en adelante · Todos los sexos · Actualizado el 7 jul 2026 · NCT07602582

A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)

  • Inland Psychiatric Medical Group., Chino
ReclutandoFase 3
Edades de 55 a 90 · Todos los sexos · Actualizado el 30 jun 2026 · NCT06947941

A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease

  • Irvine Center for Clinical Research, Irvine
  • University of California San Diego, La Jolla
  • University of California at Los Angeles, Los Angeles
ReclutandoFase 2
Edades de 50 a 85 · Todos los sexos · Actualizado el 26 jun 2026 · NCT07094516

Polyphenols and Cognitive Decline

  • University of California, Los Angeles, Los Angeles
ReclutandoSe aceptan voluntarios sanos
Edades de 50 en adelante · Todos los sexos · Actualizado el 11 jun 2026 · NCT06507254

A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)

  • Collaborative Neuroscience Network - CNS, Los Alamitos
ReclutandoFase 1Se aceptan voluntarios sanos
Edades de 45 a 85 · Todos los sexos · Actualizado el 4 jun 2026 · NCT06657768

TREAD: Time Restricted Eating Intervention for Alzheimer's Disease

  • Shiley Marcos Alzheimer's Disease Center, San Diego
ReclutandoFase 1Se aceptan voluntarios sanos
Edades de 60 en adelante · Todos los sexos · Actualizado el 26 may 2026 · NCT06548191

[18F]PI-2620 Phase 3 Histopathological Study

  • UC Los Angeles, Los Angeles
  • Esperanza Clinical, Murrieta
  • Sutter Health, San Francisco
ReclutandoFase 3
Edades de 50 en adelante · Todos los sexos · Actualizado el 22 may 2026 · NCT05641688

Trial-Ready Cohort-Down Syndrome (TRC-DS)

  • University of California, Irvine School of Medicine, Co-Enrolling through ABC-DS Only, Orange
ReclutandoEstudio observacional
Edades de 25 a 55 · Todos los sexos · Actualizado el 18 may 2026 · NCT04165109

Cardiac-Control Affecting Learning Through Mindfulness (CALM)

  • University of Southern California, Los Angeles
ReclutandoSe aceptan voluntarios sanos
Edades de 50 a 70 · Todos los sexos · Actualizado el 13 may 2026 · NCT06410157

Biomarker Exploration in Aging, Cognition and Neurodegeneration

  • University of California, Irvine, Irvine
ReclutandoFase 3Se aceptan voluntarios sanos
Edades de 60 en adelante · Todos los sexos · Actualizado el 23 ene 2026 · NCT03860857

Bumetanide in Patients With Alzheimer's Disease

  • Stanford University, Stanford
ReclutandoFase 2
Edades de 50 a 85 · Todos los sexos · Actualizado el 14 ene 2026 · NCT06052163

De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.